The growth in the incidence of different neurodegenerative diseases that leads to cognitive impairment is a growing problem worldwide. For instance, dementia affects 8.7 million people in Europe alone. Current care systems lack resources to address the growing number of patients requiring intervention, highlighting the need for new solutions. COGNIVITRA will develop a ICT-based solution to support cognitive vitality training at home. COGNIVITRA will contribute to integrating actions of formal and informal carers using a common ICT-based solution by extending cognitive and physical stimulation programs performed in the hospital or clinical environments to the community setting (e.g. home care center, patient home). COGNIVITRA targets people above 50 years old at risk of cognitive impairment and with at least one risk factor for mental health.COGNIVITRA product will integrate components for supporting cognitive and physical exercises (web-based tools and movement sensors), a centralized platform that will facilitate the interface and communication between patients and care providers.The proposed business model is to sell a monthly subscription fee to health and social care systems, primarily through consortia partners. The subscription will allow care systems to deploy the AAL-solution to different patients, enabling them to reduce costs, address bigger populations, improve the quality of life and quality of care. COGNIVITRA will engage end-users in co-creation and codesign of the COGNIVITRA product. Moreover, COGNIVITRA will deploy three pilots in relevant environments (90 installations) that will involve 200 end-users (90 primary end-users, 90 informal caregivers, 20 care professionals) to validate feasibility and adherence to the technology of the users, during the testing period of 15 months.